Case Management Study for Postpartum Depression and Intimate Partner Violence

Post-partum depression (PPD) and intimate partner violence (IPV) negatively affect the
health and well-being of millions of women each year. In turn, PPD and IPV frequently
compromise women's ability to form a strong mother-infant bond, which potentially impacts
their children's health and well-being. Limited information exists regarding the prevalence
of PPD, IPV, and the co-occurrence of the two. Similarly, empirically tested interventions
designed to improve outcomes for these women and their infants are lacking.

The current research will be conducted using a randomized controlled trial design to compare
the effectiveness of a standard screening and referral practice to an intensive case
management intervention for mothers screening positive for PPD and/or IPV. The following
research questions will be addressed in this study: 1) What is the prevalence of postpartum
depression (PPD), intimate partner violence (IPV) and co-occurrence of the two in mothers
bringing their infants to an urban pediatric primary care clinic for health maintenance
visits? 2) Compared to standard screening and referral, do mothers screening positive for
PPD and/or IPV who are assigned to a case management intervention have increased safety
promoting behaviors and higher rates of engagement with mental health services and community
resources? 3) Compared to standard screening and referral, do infants of mothers screening
positive for PPD and/or IPV who are assigned to a case management intervention have greater
compliance with well-child care and fewer acute care visits?

As per routine protocol in the Harriet Lane Clinic (HLC), all mothers bringing their infants
for a well baby visit (birth to 6 month visit) will be screened for PPD and IPV using a
brief, self-administered paper-based questionnaire at the start of the visit. Appropriate
resource and referral materials will be provided by a Family Support Counselor (FSC) in the
clinic. After this is complete, eligible mothers will be recruited to participate in the
study which will follow the above-described outcomes. There are 10 clinic sessions,
(representing morning and afternoon each weekday) where pediatric residents serve as primary
care providers and are supervised by board-certified pediatricians. The 10 clinic sessions
will be randomized (5 case management intervention sessions and 5 standard practice
sessions). Once consent is obtained, for positive screening mothers, based on the clinic
session assignment, the FSC will enroll the mother/infant dyad into either the intervention
(intensive case management) or standard practice group. All consenting mothers will be
followed every three months through the child's first birthday by telephone using a
standardized assessment survey and by child medical record review.

For negative screening mothers, consent will be obtained to track their PPD and IPV
screening responses and demographic data and to access their child's medical records through
the child's 1st birthday. Data from mother's screening negative for PPD and IPV will be
followed for three reasons: 1) this information will be used in the PPD/IPV prevalence
estimations; 2) women screening negative at one visit may become positive at the next;
keeping track of their data, therefore, will allow us to better describe the natural time
course of PPD and IPV in the post-partum period; and 3) data from this group will serve as a
control group for the randomized trial (particularly with regard to infants' health service
use).

Inclusion Criteria:

- English-speaking mothers of infants presenting for their newborn, two, four or six
month visits to their primary care provider in the Harriet Lane Clinic

Exclusion Criteria:

- none